Taconic Capital Advisors’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,325,000
Closed -$39.3M 162
2023
Q4
$39.3M Buy
+1,325,000
New +$26.4M 2.66% 11

Other funds holding IMGN

Taconic Capital Advisors's IMGN Position: Q1 2024 in Review

Taconic Capital Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,325,000 shares — an estimated $39.3M sold.

Taconic Capital Advisors first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $39.3M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Taconic Capital Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Taconic Capital Advisors sold 1,325,000 Immunogen Inc shares in Q1 2024, an estimated $39.3M.
  • Taconic Capital Advisors first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Taconic Capital Advisors's Immunogen Inc position peaked at $39.3M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Taconic Capital Advisors's 13F filing for Q1 2024, filed 15 May 2024.